Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.
Research output: Contribution to journal › Article › peer-review
Colleges, School and Institutes
|Journal||Clinical cancer research : an official journal of the American Association for Cancer Research|
|Publication status||Published - Nov 2017|